Skip to main content
Skip to content
Case File
efta-efta00773632DOJ Data Set 9Other

From: "Dr. Henry Jarecki"

Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00773632
Pages
2
Persons
0
Integrity

Summary

Ask AI About This Document

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: "Dr. Henry Jarecki" To: 'Jeffrey Epstein' <jeevacationggmail.com> Subject: FW: DeCode Date: Wed, 12 Aug 2009 23:32:26 +0000 A great idea gone bad but maybe still salvageable. And what's happened to you otherwise? From: Kozikowski, Alan [mailto Sent: Wednesday, August 12, 09 14:12 To: Dr. Henry Jarecki Subject: FW: DeCode Henry.... Opps... not good below. Hope you are good. Alan From: Yuen, Po-wai Sent: Wednesday, August 12, 2009 11:42 AM To: Kozikowski, Alan Subject: DeCode Icelandic biotech deCODE Genetics may become another casualty of tough economic times. The company announced today, (August 11) that it has only $3.8 million dollars left in its coffers •• enough to fund operations "into the latter half of the third quarter," which in Iceland runs through September. In a conference call this morning, the company said it was restructuring its business, dropping its medicinal chemistry and structural biology operations, and instead focusing on providing commercial and consumer genetics services. "We are making good progress in recasting deCODE as a leading DNA-based diagnostics company," Kari Stefansson, the company's CEO, said on the call. Going forward, said Stefansson, the three main elements of its business will be the company's consumer genome-based diagnostics business decodeME, as well as scientific services (providing genotyping, sequencing, and data management) and out-licensing for genetic markers. A $10 million deal struck in April, for example, granted genomics company Cetera a license to use deCODE-discovered markers for cardiovascular and metabolic disease risk. More such deals, or an alternative infusion of funds, will be needed to keep the company in business, however. EFTA00773632 The company's stock hit bottom in October last year, though since mid-April it has been steadily increasing from approximately 20 cents a share to 65 cents a share. (Today's stock price as of noon EST is at 61 cents a share.) The company's fall would be "a substantial blow to the field of complex trait genetics " the blog Genetic Future pointed out, noting that deCODE has "generated an insanely large number of Nature Genetics publications." EFTA00773633

Technical Artifacts (1)

View in Artifacts Browser

Email addresses, URLs, phone numbers, and other technical indicators extracted from this document.

Domainjeevacationggmail.com

Related Documents (6)

Court UnsealedJan 26, 2015

ExhibitF Journal (Black Book)

.4 (213,7 2004 .M 2005? Abby 079?$4 574 202 Abousteiman. Joanna 0503, 333 mad: . A }cannachevailer@hounasi.c Adam, Nick 19 Rue D7 Pans on 331 538 no 331 401500815 00 33 an? 341 98 p} Agag Aiejandro no 44 730 5033 Emmi: aagag?asimvestmenis.oom Agwew, Marie Ciaire 8; JO :1 51 Eaton Square London SW OQY 0207-235 ?589 (h 020? 621 0011 (w Azzedine 00 331 4272 1919 Aligiermarfe, Rufus a 521 62?? Age 13} Ruins 53H his mist} A?dridga Saffron 4? Ladbmke Rd Landon W11

92p
Court UnsealedDec 23, 2025

Epstein Will

1, JEFFREY E. EPSTEIN, of Little St. James Island, United States Virgin Islands, declare this to be my last will and testament. FIRST I hereby revoke all my prior wills and codicils. SECOND I give all my property to the Trustees of The Jeffrey E. Epstein 2001 Trust One created pursuant to an agreement dated November 8, 2001, by JEFFREY E. EPSTEIN, as Grantor, and JEFFREY E. EPSTEIN and JEFFREY A. SCHANTZ, as Trustees, to be added to the principal thereof and disposed of as provided there

24p
DOJ Data Set 10OtherUnknown

EFTA01830873

1p
OtherUnknown

Messages

DOJ EFTA Data Set 10 document EFTA01304453

4p
DOJ Data Set 8CorrespondenceUnknown

EFTA00016841

0p
DOJ Data Set 9OtherUnknown

Subject: RE: WSJ article on Deutsche Bank and Epstein charity

From: Subject: RE: WSJ article on Deutsche Bank and Epstein charity Date: Sun, 15 Sep 2019 00:32:47 +0000 Attachments: Exhibit - Timeline of Payments to Potential Co-Conspirators (002).pdf; 2019-09- — 7 09,_Epstem_Finances_-_news_articles_stimmaries.docx Following up on the below from earlier this week, this seems like as good a hook as any to provide an update on the financial side of the investigation. Our review of financial information has been extensive and robust, but ultimately it hasn't resulted in anything actionable from a charging perspective; still, so you know what we've done, we wanted to provide a rundown. Broadly speaking, we are aware of many, many financial holdings, transactions, and relationships undertaken by Epstein and various associates, including, for example, the Gratitude America entity described below. Essentially all of what the WSJ article covered had been previously reported, with the exception of the information that Gratitude America had an

3p

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.

Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.